is a regenerative medicine company that is developing cell-based therapies for cardiovascular indications. Anginera, Theregen’s lead product, is an epicardial patch designed to improve cardiac function in patients.
is a regenerative medicine company that is developing cell-based therapies for cardiovascular indications. Anginera, Theregen’s lead product, is an epicardial patch designed to improve cardiac function in patients.